United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2576_57881183-8f81-4e40-8d6b-b73447efe6d3
- Product NDC
- 71335-2576
- Form
- TABLET
- Composition / generic term
- Buspirone Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231017
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-2576-1) · 71335-2576-1
- 100 TABLET in 1 BOTTLE (71335-2576-2) · 71335-2576-2
- 60 TABLET in 1 BOTTLE (71335-2576-3) · 71335-2576-3
- 90 TABLET in 1 BOTTLE (71335-2576-4) · 71335-2576-4
- 120 TABLET in 1 BOTTLE (71335-2576-5) · 71335-2576-5
- 28 TABLET in 1 BOTTLE (71335-2576-6) · 71335-2576-6
- 180 TABLET in 1 BOTTLE (71335-2576-7) · 71335-2576-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →